Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Summary
Zenas BioPharma announced that management will present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit. The presentation will be available on-demand starting June 15, 2026, and the company will also host a webcast and archived replay on its investor relations site. Zenas describes itself as a clinical-stage biopharmaceutical company focused on therapies for autoimmune diseases. The company also highlights its lead and pipeline candidates, including obexelimab, orelabrutinib, and several earlier-stage programs.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected